Skip to content
Tenfell
Upcoming
Published 26 Feb 2025

Sprionaloctone

NHS England, Leeds · Yorkshire and the Humber

Key facts

Engagement closes
14 Mar 2025
Contract ends
30 Jun 2027
Buyer type
Health

Description

NHS England has published this Preliminary Market Engagement Notice for the Licence variation: spironolactone for acne in women. It is anticipated that there will be two separate contracts to deliver this, as outlined below. • Contract A: Prepare an application for a major (type II) MHRA Marketing Authorisation variation for spironolactone. • Contract B: Submit the pre-prepared application to the MHRA. Only current Marketing Authorisation Holders of spironolactone are eligible to bid for contract B. To register an interest in responding to this market engagement exercise and obtain a copy of the Request for Information documentation please go to: http://health.atamis.co.uk. All communications and Request for Information submissions will be conducted via Atamis.

Categories (CPV)

Similar open tenders

About NHS England, Leeds

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.